GlassScriptPhysician profile
Joseph Vincent Cotroneo
NPI 1194828251
$475.80
in general payments reported to CMS, 2019-2025
13 companies · $29.06 in 2025
The $29.06 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.61 · 2022: $96.72 · 2023: $107 · 2024: $230 · 2025: $29.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $98.03 | 2021-2022 | |
| Urgo Medical North America, LLC | $68.38 | 2024-2025 | Urgoclean Ag, Urgok2 |
| Kerecis Limited | $61.83 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tactile Systems Technology INC | $61.77 | 2024 | Flexitouch Plus, Entre Plus |
| Penumbra, INC. | $41.51 | 2023 | Indigo System |
| Mimedx Group, INC. | $35.41 | 2024 | |
| Aroa Biosurgery Incorporated | $19.71 | 2023 | |
| Kci USA, INC. | $17.79 | 2023 | Activ.A.C. |
| Paratek Pharmaceuticals, INC. | $16.51 | 2024 | Nuzyra |
| Solventum Corporation | $15.53 | 2024 | Snap, Activ.A.C. |
| Next Science LLC | $14.71 | 2023 | Blastx, Xperience, Surgx |
| Cashflow Solutions, LLC | $13.32 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Organogenesis INC. | $11.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cotroneo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.